Roche’s operating businesses are organised into two divisions:
Innovation has been one of Roche's hallmarks ever since, and many of our pharmaceutical products have become milestones in drug therapy. Upon these products we built our present world leadership in the hospital pharmacy market.
At Roche’s Pharmaceuticals Division, we view continuous innovation as the most promising way to bring new medicines to the patient. Looking to the future, our long-standing expertise in medicinal chemistry and biotechnology have put us in an excellent position to exploit the huge potential of molecular medicine.
Considered the founder of the biotechnology industry, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline for a variety of serious or life-threatening medical conditions. The company has a leading franchise in Oncology and also focuses on Immunology, Neuroscience, Metabolism and Infectious Disease.
Chugai Pharmaceutical, specialised in prescription pharmaceuticals and based in Tokyo, is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Since the start of the strategic alliance with Roche in October 2002, Chugai has been actively involved in prescription pharmaceutical R&D activities in Japan and abroad as an important member of the Roche Group. Specifically, Chugai is working to develop innovative products with global applications, focusing on the disease areas of oncology, renal disease, and bone and joint.
Roche Applied Science
Roche Applied Science supplies a broad and growing array of instruments and highly specific reagents and test kits for use in the research market and in industrial processes. Its product portfolio and capabilities are especially strong in genomics and cellomics, sciences that are transforming our understanding of disease.
Roche Molecular Diagnostics
Roche Molecular Diagnostics develops and manufactures innovative tests based on the Nobel Prize winning polymerase chain reaction (PCR) technology. PCR technology underlies a new generation of medical diagnostic tests that allow healthcare providers to select and monitor patient response to therapy or identify molecular characteristics of a disease. Roche Molecular Diagnostics’ blood-screening systems also help to ensure the safety of blood and blood products before they are used for medical procedures.
Roche Professional Diagnostics
Roche Professional Diagnostics supplies instrument systems, tests, software and services that help laboratories deliver reliable results more efficiently and cost-effectively. It is a leader in the growing market for point-of-care testing products to support clinical decision-making close to the patient, in doctors’ offices, emergency rooms and other primary and specialty care settings. RPD develops laboratory information, workflow and data management solutions as well as connectivity components to maximize laboratory efficiency – to be the industry leader in providing customer focused innovative diagnostic solutions, products and services that improve patient care.
Roche Tissue Diagnostics
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s “Smart Systems” – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized medicine through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.
Roche Diabetes Care
Roche Diabetes Care’s products are all designed with the same basic aims in mind: to help people with diabetes live healthy, productive lives and to make managing diabetes easier. Monitoring systems with integrated lancets and test strips and software for storing and analysing data are an increasingly important part of Roche’s diabetes care portfolio because they improve glycemic (blood glucose) control for many users, in addition to offering greater convenience. Activities aimed at integrating glucose monitoring and data management with insulin delivery are ongoing and may one day result in systems that closely mimic the way the healthy pancreas regulates blood glucose levels.